Susan G. Komen 3-Day Fundraising Dollars: See Your Impact Locally with Our Infographics

In 2016 Susan G. Komen announced a Bold Goal to reduce the number of current breast cancer deaths in the United States by 50% by the year 2026. That means that each dollar raised, and each step walked in the 3-Day is working towards that Bold Goal.

Dollars raised by 3-Day participants also go towards funding local research grants community health programs. This year, Komen announced $30.7 million in research funding for 98 research grants nationwide, which will predominantly focus on discovering new treatments, as well as improving our understanding of the most lethal forms of breast cancer. These grants and research are critical in helping us move closer to achieving Komen’s Bold Goal.

To fully understand your direct impact in our work, Komen released the direct impact that local research dollars has in all our local 3-Day markets. Last year, fundraising dollars contributed to the  160 total research grants in the state of Pennsylvania, and funded 186 career investigators in California.

To see the direct impact of the 3-Day in 2017, and all your hard work, look up your home state in the infographics below. These are also great informational resources to share with potential donors, or to send to donors from this year’s walks to show them just how much their support means.

Michigan

Michigan_2017_Page_1

Michigan_2017_Page_2

Minnesota

Minnesota_2017_Page_1

Minnesota_2017_Page_2

Pennsylvania

Pennsylvania_2017_Page_1

Pennsylvania_2017_Page_2

Washington

Washington_2017_Page_1

Washington_2017_Page_2

Georgia

Georgia_2017

Texas

Texas_2017_Page_1

Texas_2017_Page_2

California

California_2017_Page_1

California_2017_Page_2

How have you seen fundraising dollars at work in your local market? Tell us in the comments!

Join us for a Susan G. Komen Mission Webinar about Triple Negative Breast Cancer

Join us next Wednesday, September 14 from 11:00 a.m. – 11:30 a.m. CT as Susan G. Komen continues our 3-Day webinar series with a new webinar focused on triple negative breast cancer. You will hear from Komen Scholar, Dr. Jennifer Pietenpol, as she unwinds the complexity of triple negative breast cancer and showcases how Komen funds have aided our understanding of triple negative breast cancer and helped pioneer novel treatment options.

This webinar will be hosted by:

  • Carrie Stovall, Director, Events
  • Michelle Martin-Pozo Ph.D., Director, Research Programs at Komen
  • Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center, Director of the Vanderbilt-Ingram Cancer Center, the B.F. Byrd Jr. Professor of Molecular Oncology, and Professor of Biochemistry, Cancer Biology and Otolaryngology at Vanderbilt University School of Medicine
    • Jennifer Pietenpol, Ph.D., began her research focused on the signaling of one of the most commonly mutated genes in all of cancer: p53. More recently, Dr. Pietenpol has combined her research expertise in molecular genetics with bioinformatics to identify differences of triple negative breast cancer. Her studies have helped lead to several clinical trials aimed to help oncologists determine the most appropriate and precise treatment for breast cancer patients. Dr. Pietenpol has been recognized many times for her leadership and her work, and continues to help lead and shape cancer research nationally as demonstrated by her recent appointment to a panel advising Vice President Joe Biden’s National Cancer Moonshot.

The webinar will be 30 minutes long and you will have the opportunity to ask questions. Invite your friends, family and donors to participate and learn more about how the money you raise helps support Komen’s research.

Please send this information to your family and friends and invite them to join us, too.

WEBINAR TOPIC: Deciphering the Complexity: New Strategies for Triple-Negative Breast Cancer
DATE: Wednesday, September 14
TIME: 11:00 a.m. – 11:30 a.m. CT
REGISTER FOR THIS WEBINAR TODAY: https://attendee.gotowebinar.com/register/2966803806204000515

See you on Wednesday!